(Q44133345)

30 November 2017

title

Antipsychotic use in Australia: the patients' perspective (English)

1 reference

30 November 2017

0 references

David Castle

1

1 reference

30 November 2017

Vera Morgan

series ordinal

2

1 reference

30 November 2017

Assen Jablensky

series ordinal

3

1 reference

30 November 2017

publication date

1 October 2002

1 reference

Australian and New Zealand Journal of Psychiatry

30 November 2017

published in

1 reference

30 November 2017

volume

36

1 reference

30 November 2017

issue

5

1 reference

30 November 2017

page(s)

633-641

1 reference

Psychopharmacologic treatment of schizophrenia

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2002.01037.X

Use of antipsychosis and adjunctive medications by an inner urban community psychiatric service

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2002.01037.X

Conventional versus atypical neuroleptics: subjective quality of life in schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2002.01037.X

Subjective experiences of clozapine treatment by patients with chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2002.01037.X

Psychotic disorders in urban areas: an overview of the Study on Low Prevalence Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2002.01037.X

A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2002.01037.X

Determinants of medication compliance in schizophrenia: empirical and clinical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2002.01037.X

21 January 2018

Neuroleptic intolerance

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2002.01037.X

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2002.01037.X

Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2002.01037.X

Recent patterns and predictors of antipsychotic medication regimens used to treat schizophrenia and other psychotic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2002.01037.X

Treatment of tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2002.01037.X

10.1046/J.1440-1614.2002.01037.X

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference